State-of-the-Art Intraoperative 3D Imaging Now Offered at Nicklaus Children’s Hospital

Published on: 1/8/2025

The Medtronic O-arm®  StealthStation® S8® Surgical System for Neurosurgery, an intraoperative 2D/3D imaging device, is among the many innovative surgical technologies that are enhancing the patient care experience within the newly opened Nicklaus Children’s Kenneth C. Griffin Surgical Tower.

The technology, which is used primarily for pediatric brain and spine surgeries, displays powerful 3D images of the patient’s anatomy during surgery. When used in combination with a surgical navigation system, surgeons can view in real-time the location of implant devices relative to the patient’s anatomy, confirming optimal placement of hardware while surgery is in progress. Prior to acquiring the surgical system for neurosurgery, imaging to confirm placement of device implants was typically performed after surgery. 

Nicklaus Children’s Hospital will be the first pediatric facility in the Southeast to offer a unique feature to the Medtronic O-arm® StealthStation® S8®, Spine Smart Dose. This technology uses machine learning with existing O-arm™ images to reduce radiation by up to 70 percent in cases for both patients and clinical staff. The new system will be used in spine and cranial cases as well as neuro plastic operations.

“At Nicklaus Children’s, we are committed to offering our patients the greatest and safest surgical experience,” said Dr. Toba N. Niazi, Chief of Neurosurgery at Nicklaus Children’s Hospital. “Toward that end, we invest in the best technologies, such as the O-arm®  StealthStation® S8®, which enhances the surgeon’s ability to visualize surgical progress, and, in turn, elevates the patient’s experience and result. This equipment also minimizes imaging-associated radiation for our patients and the clinical team, enhancing safety for all.”

The O-arm® StealthStation® S8® also benefits pediatric patients with unique anatomical structures by providing their surgeons with immediate imaging and additional information about the child’s unique structure. Better visualization provides surgeons with the ability to tailor care to each patient’s needs.

About Medtronic

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com.

Read Next Read Previous

Related Press Releases

Nicklaus Children’s Hospital is the first Pediatric Hospital in South Florida to Adopt Innovative Pharmacogenomics Testing Technology to Personalize Patient Treatment Plans

Nicklaus Children’s Hospital is the first children’s hospital in South Florida to offer in-house pharmacogenomics testing with the Applied Biosystems™ PharmacoScan Solution* and GeneTitan MC Fast Scan Instrument*.

Nicklaus Children’s Hospital is the Only Children’s Hospital in Florida Now Offering Intestinal Ultrasounds to Patients with Inflammatory Bowel Disease

Nicklaus Children's Hospital is the only pediatric hospital in Florida to offer intestinal ultrasounds to children and teens, who have been diagnosed with, or are suspected of having, inflammatory bowel disease (IBD).

Nicklaus Children’s is First in Florida to Offer Carpediem Device to Enhance Dialysis Treatment of Infants
Nicklaus Children’s Hospital has acquired Mozarc Medical’s Carpediem™ Cardio Renal Pediatric Dialysis Emergency Machine designed to support dialysis treatment of newborns with acute kidney injury and fluid overload. The hospital is the first in Florida to offer this new system designed to optimize care for the smallest patients.

Nicklaus Children's Heart Institute First to Offer Innovative Heart Stent Designed for Babies

Nicklaus Children's Hospital's Heart Institute is ushering in a new era of cardiac treatment for children across South Florida. Nicklaus Children's is the first hospital in South Florida to offer the latest innovative Minima Stent from Renata Medical, the first FDA-approved heart stent that expands as the child grows. This innovation gives new hope to babies and young children with congenital heart disease, helping them avoid repeated open-heart surgeries.